Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Prev Med Public Health ; 56(2): 164-171, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37055358

RESUMO

OBJECTIVES: Sarcopenia has emerged as a significant aging-related disease that affects many facets of societal-level and patient-level public health. This study analysed knowledge of sarcopenia and associated socio-demographic factors among the general public of Malaysia in order to effectively improve its prevention and countermeasures. METHODS: A cross-sectional online survey was conducted in Selangor, Malaysia, using Google Forms among 202 Malaysian adults from January 1, 2021 to March 31, 2021. Descriptive statistics were used to analyse the socio-demographic characteristics and knowledge scores. The continuous variables were evaluated using the independent t-test, Mann-Whitney test, and one-way analysis of variance test. The Spearman correlation coefficient was employed to determine the correlation between socio-demographic characteristics and knowledge score levels. RESULTS: The final analysis included 202 participants. The mean±standard deviation age was 49.03±12.65. Only 6.9% of participants had good knowledge of sarcopenia and were aware of sarcopenia's characteristics, consequences, and treatments. Post-hoc comparisons using the Dunnett T3 test showed statistical significance in mean knowledge score and age group (p=0.011) and education level (p≤0.001). The Mann-Whitney test revealed that gender (p=0.026) and current smoking status (p=0.023) significantly influenced knowledge scores. CONCLUSIONS: The general public's knowledge of sarcopenia was found to be poor to moderate and associated with age and education status. Therefore, education and interventions by policymakers and healthcare professionals to improve public knowledge of sarcopenia in Malaysia are needed.


Assuntos
Sarcopenia , Adulto , Humanos , Estudos Transversais , Inquéritos e Questionários , Escolaridade , Povo Asiático , Conhecimentos, Atitudes e Prática em Saúde
2.
Scand J Clin Lab Invest ; 81(2): 147-159, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33528280

RESUMO

The pathogenesis involving non-alcoholic fatty liver disease (NAFLD) in the context of chronic HBV (CHB) virus infection requires to be understood for developing improved modalities of diagnosis and treatment. We retrospectively investigated the association between NAFLD and CHB virus infection in the context of liver fibrosis. Among the 522 consecutive CHB patients who underwent transient elastography between years 2013 and 2016, we studied 455 subjects in the current investigation. Controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) scores were generally higher in patients with steatosis and fibrosis or cirrhosis. Antiviral treatment had significantly reduced the hepatitis B virus (HBV) viral load. Other liver function markers showed a significant positive correlation with both CAP and LSM scores. Plasma IL-13 was independently associated with increased CAP score where every increase of 1 unit of IL-13 was associated with an increase in CAP score by 0.98 unit. CCL11 was independently associated with LSM with every increase of CCL11 by a unit that, in turn, was associated with an increase of LSM score. We found that there was a high concurrence of NAFLD among patients with CHB virus infection. The presence of metabolic syndrome and chronic inflammation in CHB virus-infected patients were two independent factors that led to the progression of liver cirrhosis, with IL-13 playing the key role in linking the metabolic with the inflammatory components.


Assuntos
Quimiocina CCL11/sangue , Fígado Gorduroso/sangue , Hepatite B Crônica/sangue , Inflamação/patologia , Interleucina-13/sangue , Cirrose Hepática/sangue , Adulto , Biomarcadores/sangue , Fenômenos Biomecânicos , DNA Viral/sangue , Diabetes Mellitus/sangue , Fígado Gorduroso/complicações , Fígado Gorduroso/metabolismo , Fígado Gorduroso/fisiopatologia , Feminino , Fator Estimulador de Colônias de Granulócitos/sangue , Antígenos de Superfície da Hepatite B/sangue , Vírus da Hepatite B/fisiologia , Hepatite B Crônica/complicações , Hepatite B Crônica/fisiopatologia , Humanos , Inflamação/complicações , Fígado/fisiopatologia , Cirrose Hepática/complicações , Cirrose Hepática/fisiopatologia , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas
3.
J Med Invest ; 56(1-2): 6-10, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19262007

RESUMO

Hyperglycemia and insulin resistance are common in many critically ill patients. Hyperglycemia increases the production of reactive oxygen species in cells, stimulates the production of the potent proinflammatory cytokines IL-8 and TNF-alpha, and enhances the expression of haem oxygenase-1, an inducible stress protein. It has been shown that administration of insulin and the semi-essential amino acid glutamine have been beneficial to the septic patient. The aim of our study is to test whether these two molecules, glutamine and insulin used in combination attenuate the proinflammatory responses in endothelial cells which have been triggered by hyperglycaemia. Our results demonstrate that a combination of insulin and glutamine are significantly more effective in reducing the expression of IL-8, TNF-alpha and HO-1 than insulin or glutamine alone.


Assuntos
Endotélio Vascular/metabolismo , Hiperglicemia/metabolismo , Inflamação/metabolismo , Estresse Oxidativo/fisiologia , Células Cultivadas , Quimioterapia Combinada , Endotélio Vascular/citologia , Endotélio Vascular/efeitos dos fármacos , Glutamina/farmacologia , Glutamina/uso terapêutico , Heme Oxigenase-1/metabolismo , Humanos , Hiperglicemia/tratamento farmacológico , Hipoglicemiantes/farmacologia , Hipoglicemiantes/uso terapêutico , Inflamação/tratamento farmacológico , Insulina/farmacologia , Insulina/uso terapêutico , Interleucina-8/metabolismo , Modelos Biológicos , Estresse Oxidativo/efeitos dos fármacos , Fator de Necrose Tumoral alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA